Total Funding
51
90
Total FundingSeed raised
Growth Score
0 pts
Heat Score
37 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3215
Engage Bio develops non-viral DNA medicines for genetic and therapeutic applications.
About the Company
Engage Bio develops non-viral DNA medicines for genetic and therapeutic applications. The company creates the Tethosome platform, which combines therapeutic DNA, messenger RNA, and lipid nanoparticle delivery technology to support durable and repeatable gene expression while reducing immune system activation. Its platform is designed to improve DNA
localization within cells and increase therapeutic protein production for applications such as gene replacement, oncology, and long-term protein expression. Engage Bio also works with research and development partners to apply its technology across multiple therapeutic programs and genetic medicine initiatives.
